MCRB (Seres Therapeutics, Inc.) Stock Market Reviews

crown

search

Read and share opinions on MCRB (Seres Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market

MCRB

Seres Therapeutics, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Seres Therapeutics to Announce Third Quarter 2025 Financial Results and Business Updates on November 5, 2025
Oct 30, 2025
Seres Therapeutics Receives Award of Up to $3.6 Million from CARB-X to Develop Liquid Formulation of SER-155
Oct 29, 2025
Seres Therapeutics to Present New Post Hoc Data From SER-155 Phase 1b Trial at IDWeek 2025, Highlighting Potential to Improve Outcomes in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant
Oct 14, 2025
All You Need to Know About Seres Therapeutics (MCRB) Rating Upgrade to Buy
Sep 9, 2025
Seres Therapeutics to Participate in H.C. Wainwright 27th Annual Global Investment Conference
Aug 27, 2025
Seres Therapeutics: Q2 Earnings Snapshot
Aug 6, 2025
Seres Therapeutics to Announce Second Quarter 2025 Financial Results and Business Updates on August 6, 2025
Jul 22, 2025
Seres Therapeutics Presents Expanded SER-155 Exploratory Biomarker Data at 2025 ASCO Annual Meeting
May 27, 2025
Seres Therapeutics (MCRB) Upgraded to Buy: What Does It Mean for the Stock?
May 23, 2025
Wall Street Analysts Believe Seres Therapeutics (MCRB) Could Rally 713.09%: Here's is How to Trade
May 16, 2025
Seres Therapeutics: Q1 Earnings Snapshot
May 7, 2025

Reviews